| dc.creator | González Cortés, Jesús Hernán | |
| dc.creator | Toledo Negrete, Juan José | |
| dc.creator | Butrón Valdez, K. | |
| dc.creator | Zapata Elizondo, V. | |
| dc.creator | Martínez Gamero, Bertha Olivia | |
| dc.creator | Treviño Cavazos, Ezequiel Enrique | |
| dc.creator | Guerra Leal, Jesús Dante | |
| dc.creator | Mohamed Hamscho, Jesús | |
| dc.date | 2015 | |
| dc.date.accessioned | 2017-03-06T12:02:56Z | |
| dc.date.available | 2017-03-06T12:02:56Z | |
| dc.identifier | http://eprints.uanl.mx/11641/1/S1665579615000459_S300_en.pdf | |
| dc.identifier | González Cortés, Jesús Hernán y Toledo Negrete, Juan José y Butrón Valdez, K. y Zapata Elizondo, V. y Martínez Gamero, Bertha Olivia y Treviño Cavazos, Ezequiel Enrique y Guerra Leal, Jesús Dante y Mohamed Hamscho, Jesús (2015) Combined therapy in diabetic macular edema. Medicina universitaria, 17 (68). pp. 153-157. ISSN 1665-5796 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/245927 | |
| dc.description | Purpose: To determine the effectiveness of three different combinations for the ‘‘loading phase’’ in the treatment of diabetic macular edema (DME), using bevacizumab (BVZ), triamcinolone (TCL) and subthreshold macular photocoagulation (SMPC). Methods: Experimental, longitudinal, prospective, comparative and blind. Patients were randomly assigned to three treatment branches: Group 1: BVZ + SMPC (12 eyes), Group 2: SMPC + BVZ + TCL (7 eyes), Group 3: BVZ + TCL (11 eyes). Treatment with BVZ and TCL was given every 4 weeks for 3 months, SMPC was applied once at the beginning of treatment. Initial and final measurements of best corrected visual acuity (BCVA), central macular thickness (CMT) and intraocular pressure (IOP) were tested.
Results: The improvement in BCVA and the reduction in CMT was statistically superior in group of BVZ + SMPCwhen compared to the other groups. There were no differences in IOP. Conclusions: Combined therapies in the ‘‘loading phase’’are a good option when treating DME. Although the group with BVZ + SMPC obtained the best results, further studies with longer followup and a higher number of participants to establish this combined therapy as the first treatment option are required. | |
| dc.format | text | |
| dc.language | en | |
| dc.publisher | UANL. Facultad de Medicina | |
| dc.relation | http://eprints.uanl.mx/11641/ | |
| dc.rights | cc_by_nc | |
| dc.subject | RM Terapéutica, Farmacología | |
| dc.title | Combined therapy in diabetic macular edema | |
| dc.type | Artículos de revistas | |
| dc.type | Artículos de revistas | |
